Indacaterol The First Once-daily Long-acting Beta2 Agonist for COPD /
Chronic obstructive pulmonary disease (COPD) is a multi-component condition that results in increasingly limited airflow, usually associated with an abnormal inflammatory response of the lung. It constitutes a major public health burden worldwide, while only very few effective therapies are availabl...
| Corporate Author: | |
|---|---|
| Other Authors: | |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Basel :
Springer Basel : Imprint: Springer,
2014.
|
| Series: | Milestones in Drug Therapy,
|
| Subjects: | |
| Online Access: | Full Text via HEAL-Link |
